Catalyst Wire Dossier Catalyst Wire Dossier

Ulonovirine

ulonovirine · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ulonovirine, covering 2025-10-16 to 2025-10-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060) [Phase 2]

See pricing